Publicaciones en colaboración con investigadores/as de Queen Elizabeth Hospital Birmingham (9)

2024

  1. Health-related quality of life in cutaneous T-cell lymphoma: A post hoc analysis of a phase 3 trial in mycosis fungoides and Sézary syndrome

    Journal of the European Academy of Dermatology and Venereology

2023

  1. Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 4, pp. 680-688

2021

  1. Real-world experience of using mogamulizumab in relapsed/refractory mycosis fungoides/Sézary syndrome

    British Journal of Dermatology

  2. Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study*

    British Journal of Dermatology, Vol. 184, Núm. 3, pp. 524-531

  3. The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T-cell lymphoma

    British Journal of Haematology, Vol. 192, Núm. 4, pp. 683-696

2020

  1. Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines

    Journal of the European Academy of Dermatology and Venereology

2018

  1. Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force

    European Journal of Cancer, Vol. 93, pp. 47-56

  2. Developments in the understanding of blood involvement and stage in mycosis fungoides/Sezary syndrome

    European Journal of Cancer

  3. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

    The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204